Key result
Urgent pericardiocentesis resolves cardiac tamponade and reveals myeloid blasts, diagnosing AML.
Why the study?
Pericardial effusion and cardiac tamponade are rare initial manifestations of acute myeloid leukemia.
Case Report (n=1)
No
This case demonstrates that life-threatening cardiac tamponade can be the initial presenting feature of acute myeloid leukemia even when peripheral blood counts show minimal abnormalities, highlighting the diagnostic utility of pericardial fluid cytology and flow cytometry.
Answers are grounded in this paper and cite their sources.
Pericardial fluid cytology may aid AML diagnosis in tamponade; extends rare presentations but leaves broader incidence and practice implications open.
Pericardial effusion and cardiac tamponade are rare initial manifestations of acute myeloid leukemia (AML). We report a 30‐year‐old man who presented with progressive dyspnea, chest pain, and orthopnea. He was hypotensive and hypoxic, and echocardiography revealed a large circumferential pericardial effusion with early right‐sided chamber collapse. Urgent pericardiocentesis drained hemorrhagic fluid, and cytology showed abundant myeloid blasts. Peripheral blood and hemodiluted bone marrow aspirate also demonstrated blasts, and cytogenetic analysis demonstrated t(8;21)(q22;q22.1)/RUNX1::RUNX1T1 fusion, establishing the diagnosis of AML with RUNX1::RUNX1T1 fusion. The patient improved after drainage and was started on standard induction chemotherapy. This case highlights that AML may present with life‐threatening tamponade despite minimal initial hematologic abnormalities and that pericardial fluid analysis can be diagnostic.
No takes yet. Share an insight, caveat, or question.
Keerthipati et al. (2026) conducted a case report in Cardiac tamponade as initial presentation of acute myeloid leukemia (AML) with RUNX1::RUNX1T1 fusion (n=1). Urgent pericardiocentesis followed by standard induction chemotherapy (cytarabine and daunorubicin) and high-dose cytarabine consolidation was evaluated on Hemodynamic improvement, diagnosis of AML via pericardial fluid analysis, and clinical resolution of pericardial effusion. Urgent pericardiocentesis drained ~700 mL of hemorrhagic fluid containing ~80% myeloid blasts (14,400 cells/μL), resolving cardiac tamponade and enabling diagnosis of AML with RUNX1::RUNX1T1 fusion.
Synapse has enriched 10 related papers. Consider them for comparative context: